Resistin in ME/CFS

Resistin, also described as Adipokine, belongs to the inflammatory group of ME/CFS (ME/CFS, CFS) markers, but reports against healthy controls point in different directions. Symptom domains tied to this marker in the source include metabolic inflammation. This entry summarises Strawbridge et al. 2019. Group-level associations like this do not translate into an individual diagnostic cut-off.

↕ InconsistentInflammatoryLOINC 42702-4

Summary

Direction in ME/CFS↕ Inconsistent — reported as both higher and lower across studies, with no consistent direction
CategoryInflammatory
Also described asAdipokine
Compared againstHC (healthy controls)
Associated symptomsMetabolic inflammation
Test typeBlood test (serum / plasma / whole blood)
LOINC code42702-4
SourceStrawbridge et al. 2019 — doi:10.1016/j.psyneuen.2019.06.019
Condition atlasME/CFS Biomarker Atlas

Other conditions where Resistin is reported

See the cross-condition hub: Resistin across conditions.

Trials, interventions and tests

Commercial test availability

Resistin — specialty laboratory test. Limited commercial availability; often research use.

Links are for reference only; availability, specimen requirements and coverage vary by location.

Related Inflammatory markers in ME/CFS

Full list: ME/CFS Biomarker Atlas.

Frequently asked questions

Is Resistin high or low in ME/CFS?

Mixed. Some studies report higher and others lower Resistin in ME/CFS compared with healthy controls, so no single direction is established. Source: Strawbridge et al. 2019.

What symptoms is Resistin associated with in ME/CFS?

The cited literature associates this marker with Metabolic inflammation. These are population-level associations and do not mean the marker causes the symptoms.

Which test measures Resistin?

It is measured as a blood test (serum / plasma / whole blood). The standard laboratory code is LOINC 42702-4. Commercial laboratories such as ARUP Laboratories list an orderable assay.

Is one abnormal Resistin result diagnostic of ME/CFS?

No. No single biomarker is diagnostic of ME/CFS. Resistin findings come from group comparisons, overlap considerably between patients and controls, and vary with study design, timing and comparison group. A result should be interpreted by a clinician alongside symptoms, history and other tests.

Is Resistin specific to ME/CFS?

No. The same marker is also reported in Long COVID in this atlas, so it reflects shared biology (for example inflammation or vascular stress) rather than a condition-specific signature.

Cite this page

Open Source Medicine Foundation. (2026). Resistin in ME/CFS: direction, evidence and what it means. OSMF Research Tracker. Retrieved October 7, 2026, from https://research.opensourcemed.info/biomarkers/me-cfs/resistin.html
Get OSMF research updates. New biomarker, trial and treatment evidence summaries by email.
Subscribe on Substack

Last reviewed: 2026-06-29 · Page generated from me-cfs.json · Browse: ME/CFS atlas · Biomarker Index · All marker pages

Disclaimer: This page is an educational synthesis of published, peer-reviewed research and is not medical advice. Biomarker findings vary across studies with case definitions, comparison groups, timing and assay methods. Direction of change reflects the predominant finding in the cited source and does not establish a diagnostic threshold. Discuss any test result with a qualified clinician.